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Community and Family Medicine (Prof M Nojomi MD, A Tehrani-Banihashemi PhD), Department of Epidemiology (M Asadi-Lari 
PhD), Department of Health Policy (H Shabaninejad PhD), Department of Health Services Management (A Ghashghaee BSc), 
Department of Neuroscience (M Safdarian MD), Department of Neurosurgery (M Khosravi MD), Health Economics Department (V 
Alipour PhD), Health Management and Economics Research Center (V Alipour PhD, J Arabloo PhD, S Azari PhD), Minimally 
Invasive Surgery Research Center (A Kabir MD), Ophthalmology Department (N Manafi MD), Pars Advanced and Minimally 
Invasive Medical Manners Research Center (A Kasaeian PhD), Preventive Medicine and Public Health Research Center (E Babaee 
PhD, M Moradi-Lakeh MD, Prof M Nojomi MD, A Tehrani-Banihashemi PhD), Iran University of Medical Sciences, Tehran, Iran (T 
Beyranvand PhD); Department of Health Policy and Management (Prof S M Aljunid PhD), Kuwait University, Safat, Kuwait; 
International Centre for Casemix and Clinical Coding (Prof S M Aljunid PhD), National University of Malaysia, Bandar Tun Razak, 
Malaysia; Clinical Research Development Center (A Khatony PhD, M Naderi MS), Department of Anatomical Sciences (M R 
Salahshoor PhD), Department of Environmental Health Engineering (Prof A Almasi PhD), Department of Epidemiology & 
Biostatistics (Prof F Najafi PhD, Y Salimi PhD), Department of Health Education & Promotion (S Siabani PhD, A Ziapour PhD), 
Department of Psychiatry (A Jalali PhD), Department of Public Health (A Kazemi Karyani PhD), Department of Radiology and 
Nuclear Medicine (M Hoseini-Ghahfarokhi PhD, E Khodamoradi PhD, S Salehi Zahabi PhD), Department of Sports Medicine & 
Rehabilitation (M Shamsi PhD), Department of Vascular & Endovascular Surgery (M Sobhiyeh MD), Medical Biology Research 
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countries, 2000–17: analysis for the Global Burden of Disease Center (F Heydarpour PhD), Research Center for Environmental Determinants of Health (Prof B Karami Matin PhD, A Kazemi 
Karyani PhD, M Moradi PhD, F Rajati PhD, S Rezaei PhD, Prof E Sadeghi PhD), Social Development and Health Promotion 
Research Center (A Khatony PhD, Y Salimi PhD, M Soofi PhD), Taleghani Hospital (F Salehi MA), Kermanshah University of 
Medical Sciences, Kermanshah, Iran (H Farzam MD, M Moradi PhD, M Sobhiyeh MD); Department of Epidemiology (A Almasi-
Hashiani PhD), Department of Pediatrics (J Nazari PhD), Health Services Management Department (S Amini PhD), Arak University 
of Medical Sciences, Arak, Iran; Medical Research Center (H M Al-Mekhlafi PhD), Jazan University, Jazan, Saudi Arabia (Prof N 
Bedi MD); Department of Medical Parasitology (H M Al-Mekhlafi PhD), Sana’a University, Sana’a, Yemen; Department of Pediatrics 
(M Temsah MD), Internal Medicine Department (Y Mohammad MD), King Saud University, Riyadh, Saudi Arabia (K Altirkawi 
MD); Research Group in Health Economics (Prof N Alvis-Guzman PhD), University of Cartagena, Cartagena, Colombia; Research 
Group in Hospital Management and Health Policies (Prof N Alvis-Guzman PhD), University of the Coast, Barranquilla, Colombia; 
Departamento de Ciencias Económicas (N J Alvis-Zakzuk MS), Universidad de la Costa, Barranquilla, Colombia; Observatorio 
Nacional de Salud (N J Alvis-Zakzuk MS), National Institute of Health, Bogotá, D.C., Colombia; Sansom Institute (A T Amare PhD), 
South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Department of Epidemiology and Biostatistics (A L 
Amit BS), Department of Health Policy and Administration (C A T Antonio MD, E A Faraon MD), Medical Informatics Unit (E A 
Faraon MD), University of the Philippines Manila, Manila, Philippines; Center for Clinical Global Health Education (S R Atre PhD), 
Department of International Health (M N Kosek MD), Department of Radiology and Radiological Sciences (N Hafezi-Nejad MD, A 
Haj-Mirzaian MD), Online Programs for Applied Learning (A L Amit BS), Johns Hopkins University, Baltimore, MD, USA; 
Department of Infectious Diseases (L Preotescu PhD), Department of General Surgery (D V Davitoiu PhD, I Negoi PhD), Carol 
Davila University of Medicine and Pharmacy, Bucharest, Romania (C Andrei PhD); Division of Human Nutrition and Health (M T 
Anegago PharmD), Wageningen University & Research, Wageningen, Netherlands; Nutrition & Food Science Research Directorate 
(M T Anegago PharmD), Ethiopian Public Health Institute, Addis Ababab, Ethiopia; Social Determinants of Health Research Center 
(M Anjomshoa PhD), Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Department of Pharmacology and Toxicology (A 
Eftekhari PhD), Research Center for Evidence Based Medicine-Health Management and Safety Promotion Research Institute (F 
Ansari PhD), School of Nursing and Midwifery (H Hassankhani PhD), Tabriz University of Medical Sciences, Tabriz, Iran (H Haririan 
PhD); Ravi Vaccine and Serum Research Institute (F Ansari PhD), Agricultural Research, Education and Extension Organization 
(AREEO), Tehran, Iran; Department of Applied Social Sciences (C A T Antonio MD), School of Nursing (P H Lee PhD), Hong Kong 
Polytechnic University, Hong Kong, China; Agribusiness Study Program (E Antriyandarti PhD), Universitas Sebelas Maret, Surakarta, 
Indonesia; Department of Sociology and Social Work (S Appiah Mphil), Kwame Nkrumah University of Science and Technology, 
Kumasi, Ghana; Center for International Health (S Appiah Mphil), Ludwig Maximilians University, Munich, Germany; School of 
Health Sciences (O Aremu PhD), Birmingham City University, Birmingham, UK; School of Nursing and Midwifery (B Armoon 
PhD), Social Determinants of Health Research Center (B Armoon PhD), Saveh University of Medical Sciences, Saveh, Iran; 
Monitoring Evaluation and Operational Research Project (K K Aryal PhD), Abt Associates Nepal, Lalitpur, Nepal; Department of 
Clinical Biochemistry (S Mir MSc, A Mosapour PhD), Fatemeh Zahra Infertility and Reproductive Health Center (P Mirabi PhD), 
Infectious Diseases and Tropical Medicine Research Center (A Rostami PhD), Nursing and Midwifery School (A Arzani DrPH), 
Social Determinants of Health Research Center (A Bijani PhD), Student Research Committee (M Zamani MD), Babol University of 
Medical Sciences, Babol, Iran (A Arzani DrPH, S Mouodi MD); Development of Research and Technology Center (S Djalalinia PhD), 
International Relations Department (M Asadi-Lari PhD), Ministry of Health and Medical Education, Tehran, Iran; Department of 
Nursing (H T Atalay MS, G Gebremeskel MSc, G T Weldesamuel MS), School of Pharmacy (G T Demoz MPharm, G G Kasahun 
MS), Aksum University, Aksum, Ethiopia; Department of Family and Community Medicine (Prof I A Ginawi MD), Department of 
Health Informatics (S Atique PhD), University of Ha’il, Ha’il, Saudi Arabia; Dr D Y Patil Medical College (S R Atre PhD), Dr D Y 
Patil University, Pune, India; School of Business (Prof M Ausloos PhD), University of Leicester, Leicester, UK; Department of 
Statistics and Econometrics (Prof M Ausloos PhD, Prof C Herteliu PhD, A Pana MD), Bucharest University of Economic Studies, 
Bucharest, Romania; Indian Institute of Public Health (A Awasthi PhD, Prof S Zodpey PhD), Indian Institute of Public Health, 
Gurugram, India (D K Lal MD, M R Mathur PhD); Department of Medicine (F W Wada MS), Department of Midwifery (K Paulos 
MS), Department of Nursing (N Awoke MS), School of Public Health (T L Lenjebo MPH), Wolaita Sodo University, Wolaita Sodo, 
Ethiopia; The Judith Lumley Centre (B Ayala Quintanilla PhD), La Trobe University, Melbourne, VIC, Australia; General Office for 
Research and Technological Transfer (B Ayala Quintanilla PhD), Peruvian National Institute of Health, Lima, Peru; School of Public 
Health (G Ayano MS), Curtin University, Perth, WA, Australia (B Duko Adema MPH); Department of Family and Community Health 
(N Kugbey PhD), Department of Health Policy Planning and Management (M A Ayanore PhD), University of Health and Allied 
Sciences, Ho, Ghana; School of Health (A A Ayele MSc), University of New England, Armidale, NSW, Australia; Department of 
Nursing (Y A Aynalem MSc, W S Shiferaw MS), Debre Berhan University, Debre Berhan, Ethiopia; Public Health Risk Sciences 
Division (A Badawi PhD), Public Health Agency of Canada, Toronto, ON, Canada; Department of Medicine (V Chattu MD), 
Department of Nutritional Sciences (A Badawi PhD), Joint Centre for Bioethics (F Manafi MD), University of Toronto, Toronto, ON, 
Canada; Department of Forensic Medicine (S M Bakkannavar MD, J Padubidri MD), Transdisciplinary Centre for Qualitative 
Methods (P Hoogar PhD), Manipal Academy of Higher Education, Manipal, India; Department of Hypertension (Prof M Banach 
PhD), Medical University of Lodz, Lodz, Poland; Polish Mothers’ Memorial Hospital Research Institute, Lodz, Poland (Prof M 
Banach PhD); Clinic for Infectious and Tropical Diseases (A Barac PhD), Clinical Center of Serbia, Belgrade, Serbia; Faculty of 
Medicine (A Barac PhD, E Dubljanin PhD), University of Belgrade, Belgrade, Serbia; Department of Ophthalmology (Prof J B Jonas 
MD), Heidelberg Institute of Global Health (HIGH) (Prof T W Bärnighausen MD, C Chansa MPH, Prof J De Neve MD, S 
Mohammed PhD), Medical Clinic V (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology) (Prof W März MD), 
Heidelberg University, Heidelberg, Germany; Department of Genetics (A Pereira PhD), Department of Global Health and Population 
(Prof S Vollmer PhD), Department of Nutrition (E L Ding DSc), Medical School (M U G Kraemer PhD), T.H. Chan School of Public 
Health (Prof T W Bärnighausen MD), Harvard University, Boston, MA, USA; University of Aden, Aden, Yemen (H Basaleem PhD); 
Barcelona Institute for Global Health (Prof Q Bassat MD), University of Barcelona, Barcelona, Spain; Catalan Institution for Research 
and Advanced Studies (ICREA), Barcelona, Spain (Prof Q Bassat MD, A Koyanagi MD); Health Human Resources Research Center 
(M Bayati PhD), Shiraz University of Medical Sciences, Shiraz, Iran; Department of Community Medicine (Prof N Bedi MD), Gandhi 
Medical College Bhopal, Bhopal, India; Department of Epidemiology and Biostatistics (M Behzadifar MSc), Social Determinants of 
Health Research Center (M Behzadifar PhD), Lorestan University of Medical Sciences, Khorramabad, Iran; School of Forestry and 
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Study 2017Environmental Studies (Prof M L Bell PhD), Yale University, New Haven, CT, USA; Centre for Tropical Medicine and Global Health 
(C Dolecek MD, S J Dunachie PhD, S Lewycka PhD), Department of Zoology (M U G Kraemer PhD), Nuffield Department of 
Population Health (D A Bennett PhD, B Lacey DPhil), University of Oxford, Oxford, UK (Prof V Jha MD); Department of Public 
Health (D A Berbada MPH, Y C D Geramo MS, D H Hayelom MPH, M B Sorrie MPH), Arba Minch University, Arba Minch, 
Ethiopia; Internal Medicine (A G Bhat MD), University of Massachusetts Medical School, Springfield, MA, USA; Department of 
Statistical and Computational Genomics (K Bhattacharyya MSc), National Institute of Biomedical Genomics, Kalyani, India; 
Department of Statistics (K Bhattacharyya MSc), University of Calcutta, Kolkata, India; Department of Global Health (S Bhattarai 
MD), Global Institute for Interdisciplinary Studies, Nepal; Research Department (P K Maulik PhD), The George Institute for Global 
Health, New Delhi, India (S Bhaumik MBBS, Prof V Jha MD); Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Italy 
(B Bikbov MD, N Perico MD, Prof G Remuzzi MD); School of Medicine (P K Maulik PhD), School of Optometry and Vision 
Science (Prof K Pesudovs PhD), School of Public Health and Community Medicine (S Karki PhD), Transport and Road Safety 
(TARS) Research Center (R Biswas MS), University of New South Wales, Sydney, NSW, Australia; School of Health Sciences (R 
Biswas MS), Swinburne University of Technology, Melbourne, VIC, Australia; Department of Basic Sciences (Prof M Sharif PhD), 
Department of Computer Engineering (M Hosseinzadeh PhD), Department of Laboratory Sciences (Prof M Sharif PhD), Department 
of Microbiology (S Valadan Tahbaz PhD), Department of Veterinary Medicine (S Bohlouli PhD), Islamic Azad University, 
Kermanshah, Iran; Department of Infectious Disease Epidemiology (O J Brady PhD), Faculty of Infectious and Tropical Diseases 
(Prof B Sartorius PhD), London School of Hygiene & Tropical Medicine, London, UK; University of Genoa, Genoa, Italy (N L 
Bragazzi PhD); Department of Biomedical Technologies (A N Briko MSc), Bauman Moscow State Technical University, Moscow, 
Russia; Department of Epidemiology and Evidence Based Medicine (Prof N I Briko DSc, P D Lopukhov Cand Of Sci [Med]), I M 
Sechenov First Moscow State Medical University, Moscow, Russia; Department of Community Medicine (S Burugina Nagaraja MD), 
Employees’ State Insurance Model Hospital, Bangalore, India; School of Public Health and Health Systems (Z A Butt PhD), 
University of Waterloo, Waterloo, ON, Canada; Al Shifa School of Public Health (Z A Butt PhD), Al Shifa Trust Eye Hospital, 
Rawalpindi, Pakistan; School of Medicine (J Campuzano Rincon PhD), University of the Valley of Cuernavaca, Cuernavaca, Mexico; 
Department of Population and Health (Prof R Cárdenas DSc), Metropolitan Autonomous University, Mexico City, Mexico; 
Department of Chemistry (N G M Gomes PhD), EPIUnit - Public Health Institute University Porto (ISPUP) (A Ribeiro PhD), 
REQUIMTE/LAQV (Prof E Fernandes PhD), Research Unit on Applied Molecular Biosciences (UCIBIO) (Prof F Carvalho PhD, Prof 
V M Costa PharmD), University of Porto, Porto, Portugal; Gorgas Memorial Institute for Health Studies, Panama City, Panama (F 
Castro MD, H Quintana PhD); Health, Nutrition and Population Global Practice (C Chansa MPH), World Bank, Lusaka, Zambia; 
Division of Epidemiology (P Chatterjee MD), National Institute of Cholera and Enteric Diseases, Kolkata, India; Population Research 
Centre (B Chauhan MPhil), Gokhale Institute of Politics and Economics, Pune, India; Department of Mathematical Demography & 
Statistics (P Dhillon PhD), Department of Population Studies (A Patle MPH, J Khan MPhil), International Institute for Population 
Sciences, Mumbai, India (B Chauhan MPhil, S Goli PhD, P Kumar PhD); Department of Epidemiology and Preventive Medicine (K L 
Chin PhD), School of Public Health and Preventive Medicine (Prof Y Guo PhD, S Li PhD, S Si PhD), Monash University, Melbourne, 
VIC, Australia; Department of Endocrinology (N Thomas), Department of Pulmonary Medicine (Prof D J Christopher MD), Christian 
Medical College and Hospital (CMC), Vellore, India (Prof S Varughese MD); Faculty of Biology (D Chu PhD), Hanoi National 
University of Education, Hanoi, Vietnam; Department of Dermatology (G Damiani MD), Department of Nutrition and Preventive 
Medicine (Prof J Sanabria MD), Case Western Reserve University, Cleveland, OH, USA; Clinical Medicine and Community Health 
(Prof C La Vecchia MD), Department of Dermatology (G Damiani MD), University of Milan, Milan, Italy; Public Health Foundation 
of India, Gurugam, India (Prof L Dandona, Prof R Dandona, G A Kumar PhD); Indian Council of Medical Research, New Delhi, India 
(Prof L Dandona); Department of Pediatrics (A H Darwish MD), Tanta University, Tanta, Egypt; Department of Immunology (Prof A 
Rafiei PhD), Department of Medicial Parasitology (Prof R Faridnia PhD); Molecular and Cell Biology Research Center (Prof A Rafiei 
PhD), Toxoplasmosis Research Center (Prof A Daryani PhD), Mazandaran University of Medical Sciences, Sari, Iran; Division of 
Women and Child Health (J K Das MD), Aga Khan University, Karachi, Pakistan; Department of Epidemiology and Biostatistics, 
Arnold School of Public Health (R Das Gupta MPH), University of South Carolina, Columbia, SC, USA; Population and 
Development (C A Davila PhD), Facultad Latinoamericana de Ciencias Sociales Mexico, Mexico City, Mexico; Department of 
Surgery (D V Davitoiu PhD), Clinical Emergency Hospital Sf. Pantelimon, Bucharest, Romania; Department of Global Health and 
Infection (K Deribe PhD), Brighton and Sussex Medical School, Brighton, UK; Department of Community Medicine (S D 
Dharmaratne MD), University of Peradeniya, Peradeniya, Sri Lanka; Health Research Section (M Dhimal PhD), Nepal Health 
Research Council, Kathmandu, Nepal; Department of Microbiology (G P Dhungana MSc), Far Western University, Mahendranagar, 
Nepal; Center of Complexity Sciences (Prof D Diaz PhD), National Autonomous University of Mexico, Mexico City, Mexico; 
Facultad de Medicina Veterinaria y Zootecnia (Prof D Diaz PhD), Autonomous University of Sinaloa, Culiacan Rosales, Mexico; 
Center of Excellence in Behavioral Medicine (H P Do PhD, C L Hoang BMedSc, T H Nguyen BMedSc), Nguyen Tat Thanh 
University, Ho Chi Minh City, Vietnam; Department of Population Health (D T Doku PhD), University of Cape Coast, Cape Coast, 
Ghana; Faculty of Social Sciences, Health Sciences (D T Doku PhD), University of Tampere, Tampere, Finland; Mahidol-Oxford 
Tropical Medicine Research Unit (C Dolecek MD, S J Dunachie PhD), Mahidol University, Bangkok, Thailand; World Food 
Programme, New Delhi, India (M Dubey PhD); Public Health (B Duko Adema MPH), Hawassa University, Hawassa, Ethiopia; 
Institute of Public Health (Prof D Rasella PhD), School of Medicine (Prof A R Durães PhD), Federal University of Bahia, Salvador, 
Brazil; Medicina Interna (Prof A R Durães PhD), Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil; Department of 
Marine Biotechnology (S Duraisamy PhD), Bharathidasan University, Tiruchirappalli, India; Clinical Epidemiology and Biostatistics 
(A Effiong MB), Department of Public Health (M N Khan MSc), University of Newcastle, Newcastle, NSW, Australia; Department of 
Microbiology (A Hasanzadeh PhD), Department of Nutrition and Food Sciences (H Poujafar PhD), Department of Pharmacology and 
Toxicology (A Eftekhari PhD), Department of Public Health (H Pourjafar PhD), Maragheh University of Medical Sciences, Maragheh, 
Iran; Biomedical Informatics and Medical Statistics (I El Sayed PhD), Pediatric Dentistry and Dental Public Health Department (Prof 
M El Tantawi PhD), Alexandria University, Alexandria, Egypt; Department of Clinical Pathology (Prof M El Sayed Zaki PhD), 
Mansoura University, Mansoura, Egypt; Department of Community Medicine (H Elkout PhD), Tripoli University, Tripoli, Libya; 
World Health Organization (WHO), Tripoli, Libya (H Elkout PhD); Department of Microbiology and Immunology (S Enany PhD), 
Department of Physiology (Prof S Magdeldin PhD), Suez Canal University, Ismailia, Egypt; Department of Midwifery (D A Endalew 
MS), Wolkite University, Wolkite, Ethiopia (A Yeshaneh BHlthSci); Division of Cancer Epidemiology and Genetics (A Etemadi PhD), 
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National Cancer Institute, Bethesda, MD, USA; College of Medicine (M Fareed PhD), Department of Pathology (N Salam PhD), 
Imam Muhammad Ibn Saud Islamic University, Riyadh, Saudi Arabia; Department of Medical and Surgical Sciences (A Farioli PhD, 
Prof F S Violante MD), University of Bologna, Bologna, Italy; Department of Psychology (Prof A Faro PhD), Federal University of 
Sergipe, São Cristóvão, Brazil; Department of Medicine (D K Mohammad PhD), Department of Neurobiology (S Fereshtehnejad 
PhD), Karolinska Institutet, Stockholm, Sweden; Division of Neurology (S Fereshtehnejad PhD), University of Ottawa, Ottawa, ON, 
Canada; Psychiatry Department (I Filip MD), Kaiser Permanente, Fontana, CA, USA; College of Graduate Health Sciences (A Radfar 
MD), School of Health Sciences (I Filip MD), AT Still University, Mesa, AZ, USA; Department of Population Medicine and Health 
Services Research (F Fischer PhD), Bielefeld University, Bielefeld, Germany; Abadan Faculty of Medical Sciences (M Foroutan 
PhD), Abadan School of Medical Sciences, Abadan, Iran; Department of Family Medicine and Primary Care (J M Francis PhD), 
University of the Witwatersrand, Johannesburg, South Africa; College of Public Health, Medical and Veterinary Science (R C Franklin 
PhD), James Cook University, Douglas, QLD, Australia; Department of Dermatology (T Fukumoto PhD), Kobe University, Kobe, 
Japan; Gene Expression & Regulation Program (T Fukumoto PhD), The Wistar Institute, Philadelphia, PA, USA; Department of 
Public Health (M T Yilma MPH), Nursing Department (R T Gayesa MS), Public Health Department (E M Roro MPH), Wollega 
University, Nekemte, Ethiopia; Department of Pharmacy (B Geta MS, G Mengistu MS), Wollo University, Dessie, Ethiopia; Unit of 
Academic Primary Care (Prof P S Gill DM), University of Warwick, Coventry, UK; Center for the Study of Regional Development (S 
Goli PhD), Jawahar Lal Nehru University, New Delhi, India; Department of Biostatistics and Epidemiology (S V Gopalani MPH), 
University of Oklahoma, Oklahoma City, OK, USA; Department of Health and Social Affairs (S V Gopalani MPH), Government of 
the Federated States of Micronesia, Palikir, Federated States of Micronesia; Postgraduate Program in Epidemiology (Prof B N G 
Goulart DSc), Federal University of Rio Grande do Sul, Porto Alegre, Brazil; Department of Dermatology (A Grada MD), Boston 
University, Boston, MA, USA; Department of Epidemiology (Prof H C Gugnani PhD), Department of Microbiology (Prof H C 
Gugnani PhD), Saint James School of Medicine, The Valley, Anguilla; Epidemiology Unit (D Guido PhD), Agency for Health 
Protection, Milano, Italy; Instituto de Patologia Tropical e Saúde Pública (R A Guimarães MS), Federal University of Goias, Goiânia, 
Brazil; Department of Epidemiology and Biostatistics (Prof Y Guo PhD), Zhengzhou University, Zhengzhou, China; March of Dimes, 
Arlington, VA, USA (Prof R Gupta MD); School of Public Health (Prof R Gupta MD), West Virginia University, Morgantown, WV, 
USA; Academics and Research Department (Prof R Gupta MD), Rajasthan University of Health Sciences, Jaipur, India; Department 
of Medicine (Prof R Gupta MD), Mahatma Gandhi University of Medical Sciences & Technology, Jaipur, India; Department of 
Nursing (M T Haile MS), St Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia; Cancer Research Center (M 
Khayamzadeh MD), Department of Epidemiology (S Sabour PhD), Department of Pharmacology (K Ramezanzadeh PharmD), 
Emergency Department (S Safari MD), Obesity Research Center (A Haj-Mirzaian MD), Ophthalmic Research Center (M Yaseri PhD), 
Research Institute for Endocrine Sciences (S N Irvani MD), Safety Promotion and Injury Prevention Research Center (N Jahanmehr 
PhD), School of Management and Medical Education (N Jahanmehr PhD), Shahid Beheshti University of Medical Sciences, Tehran, 
Iran; Global and Community Mental Health Research Group (B J Hall PhD), University of Macau, Macao, China; Department of 
Dental Public Health (N Hariyani PhD), Universitas Airlangga Indonesia, Surabaya, Indonesia; Australian Research Centre for 
Population Oral Health (N Hariyani PhD), University of Adelaide, Adelaide, SA, Australia; Department of Zoology (A I Hasaballah 
PhD), Al-Azhar University, Cairo, Egypt; Institute for Social Science Research (M Hasan MPH, A A Mamun PhD), The University of 
Queensland, Indooroopilly, QLD, Australia; Independent Consultant, Tabriz, Iran (H Hassankhani PhD); Department of Public Health 
(H Y Hassen MPH), Mizan-Tepi University, Teppi, Ethiopia; Unit of Epidemiology and Social Medicine (H Y Hassen MPH), 
University Hospital Antwerp, Wilrijk, Belgium; Department of Biostatistics and Epidemiology (H D de Hidru MPH), Department of 
Public Health (B E Tesfay MPH), Adigrat University, Adigrat, Ethiopia; Department of Pharmacology and Therapeutics (N Hossain 
MPH), Dhaka Medical College, Dhaka, Bangladesh; Department of Pharmacology (N Hossain MPH), Bangladesh Industrial Gases 
Limited, Tangail, Bangladesh; Computer Science Department (M Hosseinzadeh PhD), Department of Information Technology (A 
Mohammad Darwesh PhD), Diplomacy and Public Relations Department (A Omar Bali PhD), University of Human Development, 
Sulaymaniyah, Iraq; Division of Information and Computing Technology, College of Science and Engineering (Prof M Househ PhD), 
Hamad Bin Khalifa University, Doha, Qatar; Qatar Foundation for Education, Science, and Community Development, Doha, Qatar 
(Prof M Househ PhD); Department of Epidemiology and Health Statistics (Prof G Hu PhD), Central South University, Changsha, 
China; Department of Public Health and Community Medicine (Prof A Humayun PhD), Shaikh Khalifa Bin Zayed Al-Nahyan 
Medical and Dental College, Lahore, Pakistan; Dow Medical College (S A Hussain MD), Dow University of Health Sciences, 
Karachi, Pakistan; Department of Community Medicine (O S Ilesanmi PhD), Department of Health Promotion and Education(S E 
Ibitoye MPH), Institute for Advanced Medical Research and Training (Prof M O Owolabi DrM), University of Ibadan, Ibadan, 
Nigeria; Department of Epidemiology (Prof M D Ilic PhD), University of Kragujevac, Kragujevac, Serbia; Department of Family 
Medicine (L R Inbaraj MD), Bangalore Baptist Hospital, Bangalore, India; Institute for Physical Activity and Nutrition (S Islam PhD), 
National Centre for Farmer Health (M Rahman PhD), Deakin University, Burwood, VIC, Australia; Sydney Medical School (S Islam 
PhD), University of Sydney, Sydney, NSW, Australia; Department of Psychosis (N Jafari Balalami PhD), Babol Noshirvani University 
of Technology, Babol, Iran; Department for Health Care and Public Health (Prof M Jakovljevic PhD), Sechenov First Moscow State 
Medical University, Moscow, Russia; Faculty of Graduate Studies (A U Jayatilleke PhD), Institute of Medicine (A U Jayatilleke PhD), 
University of Colombo, Colombo, Sri Lanka; Department of Community Medicine (R P Jha MSc), Banaras Hindu University, 
Varanasi, India; Environmental Research Center (J S Ji DSc), Duke Kunshan University, Kunshan, China; Nicholas School of the 
Environment (J S Ji DSc), Duke University, Durham; Department of Earth Observation Science (P Jia PhD), Faculty of 
Geoinformation Science and Earth Observation (F B Osei PhD), University of Twente, Enschede, Netherlands; Beijing 
Ophthalmology & Visual Science Key (Prof J B Jonas MD), Beijing Tongren Hospital, Beijing, China; Department of Family 
Medicine and Public Health (J J Jóźwiak PhD), University of Opole, Opole, Poland; School of Public Health (Z Kabir PhD), 
University College Cork, Cork, UK; Infectious Diseases Research Center (H Kalani PhD), Golestan University of Medical Sciences, 
Gorgan, Iran (S Mir MSc); Department of Forensic Medicine and Toxicology (T Kanchan MD), Department of Paediatrics (Prof R 
Lodha MD), Department of Psychiatry (Prof R Sagar MD), All India Institute of Medical Sciences, Jodhpur, India; Institute for 
Epidemiology and Social Medicine (A Karch MD), University of Münster, Münster, Germany; Research and Development Team (S 
Karki PhD), Australian Red Cross Blood Service, Sydney, NSW, Australia; International Research Center of Excellence (G A Kayode 
PhD), Institute of Human Virology Nigeria, Abuja, Nigeria; Julius Centre for Health Sciences and Primary Care (G A Kayode PhD), 
Utrecht University, Utrecht, Netherlands; Department of Psychiatry (M Kumar PhD), Open, Distance and eLearning Campus (Prof P 
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N Keiyoro PhD), School of Economics (M K Muriithi PhD), University of Nairobi, Nairobi, Kenya; Department of Public Health 
(Prof Y S Khader PhD), Jordan University of Science and Technology, Irbid, Jordan; School of Food and Agricultural Sciences (N 
Khalid PhD), University of Management and Technology, Lahore, Pakistan; Department of Biotechnology (A Khalil PhD), Qarshi 
University, Lahore, Pakistan; Department of Physiology (R Khalilov PhD), Baku State University, Baku, Azerbaijan; Epidemiology 
and Biostatistics Department (E A Khan MPH), Health Services Academy, Islamabad, Pakistan; Department of Medical Microbiology 
& Immunology (Prof G Khan PhD), United Arab Emirates University, Al Ain, United Arab Emirates; Department of Population 
Sciences (M N Khan MSc), Jatiya Kabi Kazi Nazrul Islam University, Mymensingh, Bangladesh; Faculty of Health and Wellbeing (K 
Khatab PhD), Sheffield Hallam University, Sheffield, UK, Sheffield, UK; College of Arts and Sciences (K Khatab PhD), Ohio 
University, Zanesville, OH, USA; Internal Medicine and Gastroenterology Department (A Khater MD), National Hepatology and 
Tropical Research Institute, Cairo, Egypt; Academy of Medical Science, Tehran, Iran (M Khayamzadeh MD); Department of Nutrition 
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Background—Across low-income and middle-income countries (LMICs), one in ten deaths in 
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children younger than 5 years is attributable to diarrhoea. The substantial between-country 
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variation in both diarrhoea incidence and mortality is attributable to interventions that protect 
children, prevent infection, and treat disease. Identifying subnational regions with the highest 
burden and mapping associated risk factors can aid in reducing preventable childhood diarrhoea.
Methods—We used Bayesian model-based geostatistics and a geolocated dataset comprising 15 
072 746 children younger than 5 years from 466 surveys in 94 LMICs, in combination with 
findings of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017, to 
estimate posterior distributions of diarrhoea prevalence, incidence, and mortality from 2000 to 
2017. From these data, we estimated the burden of diarrhoea at varying subnational levels (termed 
units) by spatially aggregating draws, and we investigated the drivers of subnational patterns by 
creating aggregated risk factor estimates.
Findings—The greatest declines in diarrhoeal mortality were seen in south and southeast Asia 
and South America, where 54·0% (95% uncertainty interval [UI] 38·1–65·8), 17·4% (7·7–28·4), 
and 59·5% (34·2–86·9) of units, respectively, recorded decreases in deaths from diarrhoea greater 
than 10%. Although children in much of Africa remain at high risk of death due to diarrhoea, 
regions with the most deaths were outside Africa, with the highest mortality units located in 
Pakistan. Indonesia showed the greatest within-country geographical inequality; some regions had 
mortality rates nearly four times the average country rate. Reductions in mortality were correlated 
to improvements in water, sanitation, and hygiene (WASH) or reductions in child growth failure 
(CGF). Similarly, most high-risk areas had poor WASH, high CGF, or low oral rehydration therapy 
coverage.
Interpretation—By co-analysing geospatial trends in diarrhoeal burden and its key risk factors, 
we could assess candidate drivers of subnational death reduction. Further, by doing a 
counterfactual analysis of the remaining disease burden using key risk factors, we identified 
potential intervention strategies for vulnerable populations. In view of the demands for limited 
resources in LMICs, accurately quantifying the burden of diarrhoea and its drivers is important for 
precision public health.
Funding—Bill & Melinda Gates Foundation.
Introduction
Across low-income and middle-income countries (LMICs), diarrhoea causes more than half 
a million childhood deaths annually.1 In addition to this staggering loss of life, more than 
910 million childhood cases of diarrhoea per year2 are distributed unequally across the 
population, causing not only acute morbidity but also long-term disability in children who 
suffer repeatedly with enteric infections.3 National-level analyses of the burden of childhood 
diarrhoea, measured by both death rates and incidence, have exposed substantial variation. 
In LMICs in 2017, the incidence of diarrhoea ranged from less than one episode per child 
per year to more than four episodes per child per year.2 In the same population, the case-
Japan Ministry of Health, Labour and Welfare and Japan Ministry of Education, Culture, Sports, Science and Technology, during the 
conduct of the study. All other authors declare no competing interests.
Data sharing
The source code and data used to generate estimates are available online. The full sets of estimates at all geographical levels produced 
can be found online.
Page 10
Lancet. Author manuscript; available in PMC 2020 June 24.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
fatality rate of diarrhoea can vary from one per 10 000 infections to more than 20 per 10 000 
infections.4
WHO’s integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD) identified 
three approaches to reduce the burden of diarrhoea: protect, prevent, and treat.5 Healthy 
children are less likely to have severe diarrhoea episodes,6 so diarrhoeal burden can be 
reduced by prioritising good health practices from birth. As such, reducing general health 
risk factors, such as child growth failure (CGF) indicators of stunting, wasting, and under-
weight,4,7 can protect a child from diarrhoea. Preventing illness by promoting vaccination 
and improved water, sanitation, and hygiene (WASH) can similarly reduce diarrhoeal 
burden.8,9 Finally, appropriate treatment, such as oral rehydration solution (ORS), the 
efficacy of which exceeds 90%,10 can substantially reduce death resulting from disease-
associated dehydration.11,12
Distal determinants of diarrhoeal mortality, such as measurable indicators of child welfare,13 
have been geospatially mapped at the local level in Africa, including under-5 mortality,14 
CGF,15 and education levels of the broader population.16 Country-level assessment of these 
determinants can mask subnational variation and provide limited information with which to 
formulate policy.17 Furthermore, mapping interventions such as malaria nets18 and 
vaccines19 has shown the positive effects of these strategies on reducing diseases. 
Subsequently, precise mapping of diarrhoea-related interventions, including ORS coverage20 
and access to safe water and sanitation (Deshpande A, unpublished data), in addition to 
diarrhoea incidence and death, provides in-depth analysis to aid in the prevention of deaths 
associated with diarrhoea.
National trends in diarrhoeal burden are associated with (and in many cases driven by) 
national trends in risk factors associated with the protect, prevent, and treat strategy. 
Childhood stunting, poor sanitation access, and low ORS coverage are risk factors most 
strongly associated with changes in diarrhoeal burden.4 To date, no comprehensive attempt 
has been made to quantify either the subnational variation in diarrhoea or these key risk 
factors across LMICs. Several isolated studies of subnational variation in diarrhoea,21 
childhood stunting,15 WASH,22 and ORS coverage23 have shown striking variation at the 
spatial scale investigated. However, without estimates designed to be comparable across 
space and time, it is difficult to analyse such scattered information as a cohesive body of 
knowledge.
Reducing morbidity and mortality could be accomplished by targeting regions with the 
highest mortality rate, or those with the greatest total number of deaths. At the national 
scale, for example, Central African Republic was estimated to have the highest childhood 
mortality rate attributable to diarrhoea globally, at 6·9 deaths per 1000 children. Because of 
this country’s relatively small population, however, this rate translates to approximately 
4156 children dying per year.21 By contrast, in Nigeria, which has a much larger population 
than Central African Republic, an estimated 104 000 children a year die from diarrhoea, but 
the mortality rate is less than half that of Central African Republic (3·0 deaths per 1000 
children).24 A location within a country could have a relatively low risk of mortality but a 
sufficiently large population so it is a greater contributor to overall burden than other areas in 
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that country. Thus, decisions aimed at optimum burden reduction might overlook those at 
highest risk. Mapping both rates and counts can aid in the design of intervention strategies 
that efficiently save lives while also highlighting entrenched geographical disparities in 
diarrhoeal burden.
Here, we present an analysis of local variation in diarrhoeal morbidity and mortality in 
children younger than 5 years across 94 LMICs between 2000 and 2017. We used Bayesian 
model-based geostatistics and an extensive geolocated dataset (describing 3 738 327 
diarrhoea episodes across 15 072 746 children) in combination with methods from the 
Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to estimate 
posterior distributions of continuous continent-wide surfaces of diarrhoea prevalence, 
incidence, and mortality.1,2 We then aggregated our estimates at second administrative-level 
units (eg, districts in Uganda or divisions in Kenya; henceforth referred to as units), to 
identify regions with the most pronounced rate of burden reduction versus those that 
continue to have higher-than-average burden. We combined this analysis with published 
estimates of subnational CGF variation15 and new estimates of subnational variation in 
WASH (Deshpande A, unpublished data) and ORS20 to break down diarrhoeal burden. 
Finally, through these linked analyses, we identified regions most in need of tailored 
interventions to reduce the burden of this largely preventable disease.
Methods
Definitions
Diarrhoea episodes were defined as three or more loose stools over a 24-h period.4 
Diarrhoea prevalence was defined as the point prevalence of children younger than 5 years 
with diarrhoea. Incidence was defined as the number of cases of diarrhoea in children 
younger than 5 years per child per year. Mortality was defined as the number of deaths 
among children younger than 5 years due to diarrhoea per child per year. Rates per 1000 are 
presented in the figures and represent prevalence, incidence, or mortality rates per child 
multiplied by 1000). Diarrhoea burden is used throughout this Article to refer to the 
combined burden of prevalence, incidence, and mortality.
Data
We included 94 LMICs in our analysis; these countries were defined according to the Socio-
demographic Index (SDI), which assesses development based on education, fertility, and 
income.24 Where appropriate, we use designated ISO 3166-1 alpha-3 codes for countries. 
Our study complies with the Guidelines for Accurate and Transparent Health Estimates 
Reporting (GATHER) recommendations (appendix 1 pp 84–85).25
Surveys—We compiled 466 household surveys (including the Demographic and Health 
Survey [DHS], Multiple Indicator Cluster Survey [MICS], and other country-specific 
surveys) from 2000 to 2017 with geocoded information from 207 021 coordinates 
corresponding to survey clusters and 17 954 subnational polygon boundaries. We included 
surveys that asked if children younger than 5 years had diarrhoea, typically within the 
preceding 2 weeks. Potential bias attributable to seasonal variation in diarrhoea was 
Page 12
Lancet. Author manuscript; available in PMC 2020 June 24.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
addressed, as described in appendix 1 (p 5). Data were vetted for representativeness at the 
national level and subnational level, as appropriate. Data inclusion, coverage, and validation 
are further described in appendix 1 (pp 3, 9).
Spatial covariates—We compiled 15 covariates that were indexed at the subnational level 
and could possibly be related to diarrhoea prevalence, including access to roads, ratio of 
child dependents (aged 0–14 years) to working-age adults (aged 15–64 years), distance from 
rivers or lakes, night-time lights (time-varying covariate), elevation, population ratio of 
women of maternal age to children, population (time-varying covariate), aridity (time-
varying covariate), urban or rural (time-varying covariate), urban proportion of the location 
(time-varying covariate), irrigation, number of people whose daily vitamin A needs could be 
met, prevalence of under-5 stunting (time-varying covariate), prevalence of under-5 wasting 
(time-varying covariate), and diphtheria-tetanus-pertussis immunisation coverage (time-
varying covariate). We also included the Healthcare Access and Quality Index,26 percentage 
of the population with access to improved toilet types, and percentage of the population with 
access to improved water sources (as defined by WHO and UNICEF’s Joint Monitoring 
Programme) as national-level time-varying covariates. We filtered these covariates for 
multicollinearity in each modelling region (appendix 1 pp 5–6) using variance inflation 
factor (VIF) analysis with a VIF threshold of 3.27 Covariate information, including plots of 
all covariates, is detailed in the appendix 1 (pp 25–26, 90–96).
Statistical analysis
Geostatistical model—Prevalence data were used as inputs to a Bayesian model-based 
geostatistical framework. Briefly, this framework uses a spatially and temporally explicit 
hierarchical logistic regression model to predict prevalence. Potential interactions and non-
linear relations between covariates and diarrhoea prevalence were incorporated using a 
stacked generalisation technique.28 Posterior distributions of all parameters and 
hyperparameters were estimated using R-INLA version 19.05.30.9000.29,30 Uncertainty was 
calculated by taking 250 draws from the estimated posterior joint distribution of the model, 
and each uncertainty interval (UI) reported represents the 2·5th and 97·5th percentiles of 
those draws. Models were run independently in 14 geographically distinct modelling regions 
based on the GBD 2010 study,31 and one country-specific model in India. Analyses were 
done using R version 3.5.0. Maps were produced using ArcGIS Desktop 10.6. Additional 
details are provided in appendix 1 (pp 6–8).
Post estimation—Estimated prevalence was converted into incidence using an average 
duration of a diarrhoea episode of 4·2 days4 (appendix 1 p 9). We converted incidence 
surfaces to mortality surfaces by multiplying the incidence values by country-specific and 
year-specific case-fatality rates (which did not vary subnationally). We calibrated our 
continuous prevalence estimates to those of prevalence, mortality, and incidence from GBD 
2017. However, we did not calibrate prevalence or incidence in South Africa because of 
unreasonably low estimates in this location in the GBD 2017 study. We then calculated 
population-weighted aggregations of the 250 draws of diarrhoea prevalence, mortality, and 
incidence estimates at the country level, first administrative-level unit, and second 
administrative-level unit (hereafter referred to as unit). This calculation resulted in estimates 
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for 24 143 units within 94 countries. Geographical inequalities were quantified as the 
relative difference between each unit and the respective country average. We also estimated 
inequality using the Gini coefficient,32 which summarises the distribution of each indicator 
across the population, with a value of 0 representing perfect equality and 1 representing 
maximum inequality (appendix 1 p 12).
Counterfactual analyses using diarrhoea risk factors—Following the GAPPD 
framework, we did a post-hoc counterfactual analysis using subnational estimates of risk 
factors according to GBD 2017, including reducing prevalence of childhood stunting and 
childhood wasting (protect), access to improved sanitation and improved water (prevent), 
and increasing ORS coverage (treat). Some known diarrhoea risk factors (eg, low coverage 
of rotavirus vaccine, or no or partial breastfeeding) were not included because subnational 
estimates are currently not available for all 94 LMICs included in this study. We used the 
counterfactual analysis to estimate the number of deaths averted because of changes in CGF 
and WASH risk factors (appendix 1 pp 61–62).
Model validation—Models were validated using source-stratified five-fold cross 
validation. Holdout sets were created by combining randomised sets of second 
administrative unit cluster-level datapoints. Model performance was summarised by the bias 
(mean error), total variance (root-mean-square error), 95% data coverage within prediction 
intervals, and correlation between observed data and predictions. When possible, estimates 
were compared against existing estimates. All validation procedures and corresponding 
results are provided in appendix 1 (p 9).
Role of the funding source
The funder had no role in study design, data collection, data analysis, data interpretation, or 
writing of the report. RCR had full access to all data in the study and had final responsibility 
for the decision to submit for publication.
Results
Our model produced estimates of local diarrhoea prevalence, incidence, and mortality for 94 
LMICs yearly from 2000 to 2017, showing subnational spatial and temporal variation. A 
large variation in diarrhoeal burden was seen, both between and within countries, and 
striking differences in trends were noted over time by location. Although, in many countries, 
rates of diarrhoeal morbidity and mortality were disproportionally high in less-populated 
rural areas, the absolute burden of diarrhoeal mortality was typically concentrated in highly 
populated urban centres. By integrating these subnational estimates of mortality with similar 
estimates of leading risk factors, improvements in WASH (Deshpande A, unpublished data) 
and prevention of CGF (relative to levels in 2000) were estimated to avert 46 000 (95% UI 
32 000–170 000) and 245 000 (177 000–940 000) child deaths in 2017, respectively. The full 
array of our model outputs is provided in appendix 2 (pp 1–950), and online.
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Incidence of diarrhoea
In 2017, Yemen had the most units exceeding five cases of diarrhoea per child per year (124 
units), with Afghanistan (16 units) the only other country with such high incidence (figure 
1A). It is unsurprising that Yemen had the most subnational units with high incidence, 
because the country had had the highest national incidence of diarrhoea globally, with 4·7 
(95% UI [4·0–5·7]) cases per child per year. In 2017, the highest incidence of diarrhoea for 
sub-Saharan Africa was in Cameroon (4·8 [95% UI 2·9–7·4] cases per child per year in 
Mayo-Danay department, Extrême-Nord); for Latin America the highest incidence was in 
Guatemala (4·7 [3·7–5·8] cases per child per year in San Antonio Suchitepéquez department, 
Suchitepéquez; and 4·4 [3·5–5·5] cases per child per year in San Miguel Panán department, 
Suchitepéquez); and for southeast Asia the highest incidence of diarrhoea was in Papua New 
Guinea (3·5 [2·7–4·5] cases per child per year in Koroba-Kopiago district, Hela). Massive 
variation within regions is exemplified in central Asia and south Asia, where the highest 
incidence of diarrhoea by country spanned from 2506th to 24 391st across all LMICs (2·8 
[95% UI 2·1–3·6] cases per child per year in Moskva district, Khatlon, Tajikistan; and 0·7 
[0·4–1·3] cases per child per year in Aşgabat district, Aşgabat, Turkmenistan; figure 1A). 
Maps of upper and lower bounds for the uncertainty on incidence can be found in appendix 
1 (p 47).
As with variation between countries, substantial variation was seen within most countries. 
16 countries had at least one unit with an estimated incidence of diarrhoea more than 1·0 
case per child per year higher than the national average (figure 1B). The district of Darqad, 
Takhar, Afghanistan, had an incidence of 6·3 (95% UI 4·2–9·5) cases per child per year, 
which was 2·3 cases per child per year higher than the national average (4·0 [2·8–5·3] cases 
per child per year). Conversely, only nine countries had units with incidence less than 1·0 
case per child per year lower than their country average (appendix 2 pp 3–4, 478–950). 
Countries with large relative geographical inequality include Guyana, where the rate in the 
Marudi council, Upper Takutu-Upper Essequibo, was 2·4 (95% UI 2·0–3·1) cases per child 
per year, which is much higher than the country average of 1·2 (0·9–1·5) cases per child per 
year. It is important to note that the comparison in Afghanistan also illustrates a technical 
difficulty in summarising correlated uncertainty. In Afghanistan, the 95% UI for the 
estimated incidence of diarrhoea in Darqad overlaps that for average incidence across the 
country, but these UIs are based on summarising aggregations from draws of correlated 
incidence surfaces. In every draw from the posterior distribution of incidence, Darqad had an 
incidence at least 86·0% higher than that draw’s estimated country incidence.
The substantial reduction in overall diarrhoeal burden since 2000 has not translated into a 
consistent reduction in incidence of diarrhoea. 5729 (24%) of 24 139 units had an increase 
in childhood diarrhoea incidence from 2000 to 2017 (figure 1C). Laos in particular 
contained 24 units with annual rates of change in diarrhoea incidence exceeding 5% per 
year. Conversely, among all units that had decreases in incidence, Nigeria saw the greatest 
number of units (n=40) with annual declines in diarrhoea incidence of 7% or more.
Incidence data provide information on the per person risk of disease. However, some units 
with the highest incidence of diarrhoea are sparsely populated. On the other hand, many 
units with the highest incidence of diarrhoea and moderate rates of diarrhoea have 
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considerable populations. For example, in 2017, five units in Punjab, Pakistan (Dera Ghazi 
Khan, Faisalabad, Gujranwala, Lahore, and Multan) were estimated to have more than 21 
(95% UI 14·8–28·9) million cases of diarrhoea in children younger than 5 years (figure 1D). 
Each of these units had an incidence less than 1·9 (95% UI 1·3–3·0) cases per child per year. 
By contrast, Wadhrah district in Hajjah, Yemen, had a high incidence of diarrhoea (5·5 [95% 
UI 4·3–7·0] cases per child per year), but because of this district’s relatively small child 
population, there were only 9890 (7766–12 723) cases of diarrhoea (figure 1D). These 
incidence data suggest that interventions focused on lowering the absolute burden of 
diarrhoea might best be focused on urban areas, although this focus risks exacerbating 
existing geographical disparities.
Mortality from diarrhoea
Similar to patterns noted previously on a subnational map of diarrhoeal mortality in Africa,
21
 substantial diarrhoeal burden was seen in several countries in the Sahel region of Africa, 
with Birao in Vakaga, Central African Republic, having the highest mortality rate globally of 
8·2 (95% UI 6·8–9·7) deaths per 1000 children in 2017 (figure 2A). Seven countries had at 
least one unit exceeding five deaths per 1000 children, and all were located in Africa. For 46 
countries, the GAPPD goal of decreasing childhood diarrhoeal mortality to less than one 
death per 1000 children was achieved in every second administrative-level unit by 2017 
(appendix 2 pp 5–477). Global variation in diarrhoea mortality was so vast that rates for 
many countries remain several orders of magnitude lower than those in central sub-Saharan 
Africa (figure 2A).
Similar to incidence, substantial within-country variation was noted in diarrhoeal mortality. 
As previously highlighted in our Africa-focused analysis,21 some units in Nigeria in 2017 
were far above the country average. Of the 100 largest deviations above the national mean 
mortality rate, 86 occurred in northern Nigeria (figure 2B). Only units in Chad, Kenya, and 
Nigeria had rates greater than one death per 1000 less than their country average mortality 
rate (figure 2B). When the analysis was done in terms of relative deviation from the mean, 
different patterns of subnational variation became apparent. Indonesia stood out as having 
many units within Papua that were more than three-fold the country average; in particular, 
the Boven Digoel Regency of Papua, Indonesia, was estimated to have a diarrhoeal mortality 
rate 3·4 times the national average (figures 3A, B). Similarly, 736 units of Mexico were 
estimated to have mortality rates more than double the national average (figure 2B). 
Although Nigeria had massive absolute deviations, units with the highest absolute deviations 
were 169·0% (95% UI 114·2–256·5) the national average (figure 2B). Maps of upper and 
lower bounds for uncertainty on incidence can be found in appendix 1 (p 48).
Unlike incidence of diarrhoea, diarrhoeal mortality declined in most units from 2000 to 
2017. 8658 (36%) of 24 143 units showed reduced rates of childhood diarrhoeal mortality, 
by more than 10% per year (figure 2C). The greatest declines in diarrhoeal mortality were 
seen in south and southeast Asia and South America, where 54·0% (95% UI 38·1–65·8), 
17·4% (7·7–28·4), and 59·5% (34·2–86·9) of units, respectively, recorded decreases in deaths 
from diarrhoea greater than 10%. Diarrhoeal mortality was estimated to have increased in 
only 112 (0·5%) units over this time, exclusively in Central African Republic, Indonesia, 
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Kenya, South Sudan, and Tunisia. Although massive imbalances in mortality rates within 
Africa persisted in 2017, most diarrhoeal deaths in LMICs occurred outside of Africa. 
Importantly, because of the juxtaposition of mortality rate to population size, the five units 
with the largest number of diarrhoeal deaths were all outside of Africa, specifically in 
Punjab, Pakistan (Dera Ghazi Khan, Faisalabad, Gujranwala, Lahore, and Multan; figure 
2D). By comparison, the total number of deaths in these five units was more than double the 
total estimated diarrhoeal deaths in Liberia, Rwanda, and Togo.
Geographical inequality in diarrhoeal mortality
Within analyses of geographical inequality, focusing on maximum deviations from the 
country mean can mask subnational variation in space and time. Two exemplars of this 
masking are Indonesia (where units with the greatest deviation changed over time) and Peru 
(where the shape of the distribution of inequality changed even though the maximum 
deviation remained mostly stable; figure 3). In 2000, the units within Indonesia farthest from 
the mean were all within the first administrative-level units (provinces) of modern-day 
Gorontalo, Nusa Tenggara Barat, Sulawesi Barat, and Sulawesi Tengah, with the largest 
relative deviation in the East Lombok Regency in Nusa Tenggara Barat (101·4% the national 
mortality rate; figures 3A, 4). By 2017, units in Papua were almost four times the Indonesian 
national average (figures 3B, 4). Units in Papua went from not ranking in the 60 units with 
the highest deviation in Indonesia in 2000 to having the 29 units with the highest deviations 
from the country average in 2017.
In Peru, several units had substantial deviations from the national average in 2000. The 
maximum relative geographical inequality occurred in Requena province, Loreto, with 0·80 
(95% UI 0·65–0·97) deaths per 1000, versus a country mortality rate of 0·4 (0·4–0·5) deaths 
per 1000 children, a relative deviation of 83·7%. Since 2000, Peru has seen substantial 
reductions in diarrhoeal mortality, and yet, in 2017, mortality in Requena province, Loreto, 
was 56·8% higher than the country average. Although the maximum relative deviation 
increased over this period, the distribution of inequality shows a different pattern. In 2000, 
58 of 196 provinces in Peru had mortality rates at least 20% higher than the country average 
(figure 3C); however, in 2017, only 34 provinces had mortality rates at least 20% higher than 
the country average (figure 3D).
Drivers of geographical inequality in diarrhoeal mortality
A risk factor can drive the risk of diarrhoeal mortality by increasing the chance that either a 
child is infected, infection develops into a disease episode, or an episode results in death. 
Both CGF and WASH risk factors were used as covariates in the diarrhoea prevalence model 
because they are predictive of infections that lead to diarrhoea.7,22 Conversely, ORS 
coverage was not used because there is clinical evidence that ORS prevents mortality from 
diarrhoea,11,12 but there is no evidence that it affects diarrhoea prevalence or incidence. 
Because of the possibility for circularity, post-hoc correlative analyses between the 
subnational variation in diarrhoeal mortality and the subnational variation in CGF and 
WASH must be interpreted carefully. However, consistent with the logic of previous risk 
factor analysis,3 excluding these known drivers of diarrhoea incidence would diminish the fit 
and usefulness of the output more than the potential loss of interpretation due to circularity. 
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It is important to note that by using both stacked generalisation and the Gaussian process, 
which incorporates estimates of spatial and temporal autocorrelation, diarrhoeal mortality 
patterns are not a simple direct function of the risk factors used. Most importantly, the 
counterfactual analysis is based on externally derived risk ratios for each level of each risk 
factor.
To assess drivers of the temporal trends in diarrhoeal mortality, we did a counterfactual 
analysis by comparing the estimated number of diarrhoeal deaths in 2017 to the scenario in 
which these risk factors had been at their 2000 levels. For the primary counterfactual 
analysis, we did not include ORS because only a few studies have quantified ORS efficacy 
precisely and, thus, there is no universally accepted risk ratio for its efficacy. A 
counterfactual analysis that includes ORS is presented in appendix 1 (pp 61–62). Additional 
factors that affect death rates and counts, such as changes in population structure and size 
and sociodemographic factors, were kept at their 2017 levels. Reductions in CGF averted 
245 000 deaths, and 46 000 deaths were averted by improvements in WASH (figure 5D). In 
units where one or both risk factor groups improved from 2000 to 2017, we estimated 297 
000 deaths were averted because of combined changes in WASH and CGF risk factors 
(figure 5B). The largest attributable relative reductions in diarrhoeal mortality in units where 
at least one child was estimated to have died from diarrhoea in 2017 were seen in India, 
Myanmar, Rwanda, and Somalia, where gains were mainly attributable to concurrent 
reductions in CGF (figures 5A, C). Conversely, the largest absolute attributable reductions in 
diarrhoeal mortality were in Ethiopia, India, Niger, and Pakistan. In Lahore, within the 
Punjab province of Pakistan, these gains were almost entirely due to improvements in 
WASH, whereas in the units within Ethiopia, India, and Niger, the averted deaths were 
almost entirely due to reductions in CGF (figures 5B, D). Although many regions that saw 
deaths averted because of WASH also had improvements associated with CGF, there were 
regions in Angola and Pakistan where the reduction in diarrhoea-related mortality was 
mainly driven by WASH (figure 5C). In 2000, across all LMIC units, 68·0–99·2% of 
childhood diarrhoeal deaths were attributable to either CGF or WASH risk factors. In 2017, 
the range increased slightly to 60·1–99·0% (appendix 1 pp 61–62).
Compared with other modelled regions, much of sub-Saharan Africa had a disproportionally 
high burden of diarrhoeal disease. Inequality, as measured by the Gini coefficient across 
units within sub-Saharan Africa, remained mostly constant in sub-Saharan Africa from 2000 
(0·30) to 2017 (0·33). We identified units with child populations at highest risk of death due 
to diarrhoea, defined as units with 20% of the population in Africa living in areas with the 
highest mortality rates (figure 6A). No combination of risk factors that drove high diarrhoeal 
mortality was discernible; however, units had at least one risk factor at a high level (figures 
6B–D). Of 565 units accounting for 20% of children with the highest diarrhoeal mortality 
risk in 2017, 447 were also among those with the highest risk in 2000. The other 118 units 
that became relatively worse from 2000 to 2017 were predominantly in South Sudan (n=45), 
Central African Republic (n=39), and Madagascar (n=21). In units in South Sudan, although 
ORS decreased slightly on average (2·7%), there was a notable decline in average prevalence 
of childhood stunting across the 45 units (9·6%; figure 6D). As with high-burden areas in 
2017, the risk factors that correlated with improvements from 2000 to 2017 were varied. For 
example, of the 295 units that transitioned out of the lower 20% from 2000 to 2017, 53 came 
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from Liberia. In these units, surprisingly, both ORS coverage and access to improved 
sanitation declined on average from 2000 to 2017 (average ORS coverage declined by 
14·1% and average access to improved sanitation declined by 11·7%; figures 6B, C). 
Conversely, and more consistent with the improvements in these units of Liberia, childhood 
stunting consistently improved from 2000 to 2017 (childhood stunting decreases ranged 
from 14·4% to 25·4%; figure 6D).
Discussion
Over the past 18 years, substantial reductions have been noted in diarrhoeal mortality, but 
these improvements have not been recorded uniformly across LMICs. Although only 112 
(0·5%) of 24 143 units had increases in mortality rates from 2000 to 2017, 5729 (24%) units 
saw an increase in incidence of childhood diarrhoea over this period. While some units with 
high diarrhoeal burden in 2000 have subsequently noted impressive reductions, other units 
with historically high diarrhoeal burden have seen some of the most meagre improvements. 
Globally, most of the diarrhoeal burden is in sub-Saharan Africa and south Asia, but we 
recorded substantial variation within countries in these subcontinents. Moreover, even in 
regions with relatively low diarrhoeal burden, we identified units that far exceeded their 
respective country’s averages. Our estimates identified the units of each country where 
diarrhoeal burden was disproportionally high, pinpointing the locations most in need of 
targeted interventions.
Identifying a country’s worst-performing units also leads to awareness of the extent of 
geographical inequality, measured by the range of relative deviation from the mean. It 
likewise pinpoints if these units are left behind consistently over time. In Peru, some metrics 
of geographical inequality seem to be mostly consistent from 2000 to 2017. However, deeper 
analysis into the distribution of burden across the country showed that more than half of its 
worst-performing units substantially improved relative to others in the country. Only a few 
Peruvian units east of the Andes seem to be left behind. Conversely, in Indonesia, the worst-
performing units in 2000 actually improved more than average, whereas units in Papua 
became substantially worse relative to the rest of the country, leading to units exceeding the 
country average by almost 350%.
The different subnational patterns that emerge between relative and absolute deviations are 
echoed when comparing units with the highest mortality rates versus those units where most 
children die from diarrhoea. Across all LMICs, even though units with the highest mortality 
risk were all in sub-Saharan Africa, the five units where most children died were all in 
Pakistan. These same patterns hold within many countries. In the Democratic Republic of 
the Congo, most deaths from diarrhoea occurred in the capital city of Kinshasa, where the 
death rate was 1·5 (95% UI 1·3–1·9) deaths per 1000 children; however, the second 
administrative-level unit with the highest death rate (Kazumba, Kasaï; 2·0 [1·6–2·4] deaths 
per 1000 children) had an estimated 307 (251–368) childhood deaths in 2017 because of its 
small population size (figure 2). When attempting to further reduce diarrhoeal burden in a 
country or region, interventionists, policy makers, and other stakeholders must consider and 
balance the needs of both locations with the highest risk and locations with the highest 
burden.
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Changes in diarrhoeal burden are due to myriad related drivers, but findings of a study3 
showed that CGF and poor access to improved WASH were most associated with global 
reductions in the burden of diarrhoea. Although there are other important risk factors for 
diarrhoea (eg, poor rotavirus vaccine coverage), we did a counter-factual CGF and WASH 
risk factor analysis. Using newly available subnational estimates, we have provided a deeper 
understanding of the drivers of past success and location-specific needs to prevent future 
deaths. Large portions of sub-Saharan Africa have seen improvements because of reductions 
in CGF. Likewise, reductions in diarrhoeal deaths in Ethiopia have coincided with 
improvements in access to better sanitation. We identified second administrative-level units 
of Ethiopia, India, Niger, and Pakistan where reductions in CGF and WASH risk factors 
since 2000 have averted more than 1000 childhood deaths due to diarrhoea. Some of the 
regions that have seen the slowest improvements can also be linked to risk factors. In much 
of Pakistan, for example, small improvements in WASH have been overwhelmed by 
increases in CGF (figure 5). Although it is unlikely that risk factors will be eliminated 
completely, and thus counting all deaths still attributable to a risk factor is slightly 
misleading, we did identify patterns relating disproportionately high values of risk factors 
with disproportionally high burden. In sub-Saharan Africa, no combination of risk factors 
was found that needed reduction across the region; rather, in different locations of high 
burden, a different suite of risk factors seemed to be associated with the high risk of death 
due to diarrhoea (figure 6).
In the future, our analysis could aid in targeting of site-specific interventions, for example, to 
units of India, Indonesia, and Nigeria that did worse than their respective country average 
and had higher than country-average levels of childhood stunting. Although nationwide 
campaigns to reduce childhood stunting have a role in averting further unnecessary deaths, 
focused interventions in the worst-performing units might reduce the recorded substantial 
geographical inequality in diarrhoeal burden. Our results did not always indicate that every 
unit needing improvements required reductions in all risk factors, even within one country. 
As an example, although most poorly performing units within Nigeria had lower than 
average access to improved sanitation and ORS coverage, almost 10% of children in poorly 
performing units lived in locations estimated to have better than average sanitation and ORS 
coverage. Careful consideration of location-specific risk factors is necessary to optimally 
design intervention programmes.
Limitations associated with our analysis include inherent biases in survey data, which are 
associated with data obtained with recall biases. There is also uneven data coverage in space 
and time, in particular from zones of conflict and political instability (eg, Afghanistan, Iraq, 
Pakistan, Syria, and Yemen). Regarding the geospatial modelling framework, our approach 
is designed to optimise out-of-sample predictive validity and, as such, it is difficult to do 
inferential analyses. Our spatial and temporal autocorrelation assumptions might smooth 
over focal epidemics. Additionally, our model does not distinguish differences in rates of 
disease or death by causes of diarrhoea because we are currently unable to fully model all 
causes of diarrhoea. For this study, we assume that the case-fatality rate is constant for any 
particular year within any particular country. This assumption is unlikely, but since it is more 
likely that the places with higher than average prevalence are likely to be the same places 
with a higher than average case-fatality rate, our observations about subnational inequality in 
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diarrhoea mortality probably underestimate these quantities. As previously mentioned, the 
risk factor analyses must be interpreted with care. CGF and WASH risk factors are used as 
covariates within the diarrhoea model, so it is unsurprising that the final diarrhoeal burden 
estimates correlate with those covariates. On the other hand, because of both the 
spatiotemporal smoothing that occurs through the Gaussian process and the stacked 
generalisation beforehand, it is not necessary for the final output to correspond with the 
covariates used in the regression. Although ORS was not used in the prevalence model, 
many of the base covariates used in diarrhoea (eg, elevation or population density) were used 
in the ORS model.
Our counterfactual analysis assumed that each risk factor affects diarrhoeal mortality and 
changes through time independently of all other risk factors. Accurately capturing and 
quantifying the covariation of these risk factors in space and time would further improve the 
use of that analysis. Our study also does not address the protective effect of breastfeeding 
with potential for the reduction of diarrhoeal burden.39 Breastfeeding can account for some 
of the lower rates of reduction in diarrhoea incidence and would be useful to investigate in 
future studies. Diarrhoea is a common symptom triggered by different causes and, to further 
focus preventive health-care strategies, a more in-depth analysis of diarrhoea causes should 
be done in future studies. Finally, despite the availability of vaccines to rotavirus, which is 
the leading cause of diarrhoea, we did not include coverage of this vaccine in our risk factor 
analysis because subnational estimates of rotavirus vaccine coverage are not yet available for 
all LMICs.
Because geospatial information is available for some causes of diarrhoea, estimating the 
subnational variation in those pathogens would help the interpretations and 
recommendations resultant from this work. Our current modelling framework aggregates 
ages to all children younger than 5 years but, in view of the strong relation between the case-
fatality ratio and age, an age-specific model would be more informative. Our current 
framework prioritises prediction over inference. There is an increased need in building 
inferential models that can be used to infer the effect of interventions. Finally, our model 
assumes that every child within a population is equally likely to become infected and, on 
infection, is equally likely to develop disease or die. It does not address the vicious cycle of 
repeated enteric infections in the same individual that causes more severe symptoms. 
Incorporating these dynamics into our modelling framework can improve accurate 
accounting of the long-term burden of diarrhoea and quantification of those who are most 
vulnerable.
Every year, more than half a million children in LMICs die from diarrhoea; however, with 
treatment, most of these deaths can be averted. Our results serve as a new tool to pinpoint 
where these deaths occur. By establishment of good health practices from birth, children can 
be protected from enteric infections resulting in serious diarrhoeal episodes. Finally, by 
ensuring access to healthy environments, exposure to enteric pathogens can be prevented. 
Optimising reduction of diarrhoeal burden can be achieved by focusing on locations with the 
highest risk or those with the highest burden; either way, a detailed understanding of 
diarrhoeal morbidity and mortality, in addition to risk factors that drive diarrhoea, is 
necessary at the spatial scale at which policy is implemented. This work provides the data 
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necessary to formulate effective policies and precision public health programmes to 
ultimately stop the preventable loss of so many young lives.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Research in context
Evidence before this study
In the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017, 
diarrhoea was the third leading cause of death among children younger than 5 years and 
was reported to have caused an estimated 534 000 deaths. WHO’s integrated Global 
Action Plan for the Prevention and Control of Pneumonia and Diarrhoea calls for 
protection of children from disease by establishing good health practices, preventing 
infection from occurring, and treating infections when they occur. Over the past decade, 
large reductions in childhood mortality due to diarrhoea have been recorded across low-
income and middle-income countries (LMICs), in part attributable to strategies to reduce 
child growth failure (CGF), improve water, sanitation, and hygiene (WASH), and increase 
access to oral rehydration therapy and vaccines. Several studies have recorded substantial 
between-country variation in both the likelihood of a child experiencing a diarrhoea 
episode and that episode resulting in death. To reduce the burden of childhood diarrhoea, 
the remaining subnational regions with the highest prevalence and those with the lowest 
levels of interventions should be identified.
Added value of this study
We present the first high-resolution subnational estimates of diarrhoeal morbidity and 
mortality from 2000 to 2017 in LMICs. We used Bayesian model-based geostatistics and 
an extensive geolocated dataset in combination with established methods from GBD 
2017 for both burden estimation and risk factor association. We did a systematic 
assessment of local variation to estimate the distribution of diarrhoea prevalence, 
incidence, and mortality. Our estimates show considerable subnational variation in the 
diarrhoeal burden for children younger than 5 years. We synthesised new subnational 
estimates of the key risk factors of diarrhoea to discern averted deaths attributable to 
improvements in these drivers of diarrhoeal morbidity and mortality. Finally, when 
focusing on subnational regions with the highest remaining burden, we identified not 
only which regions of the world have the highest diarrhoeal burden and continued 
geographical inequalities but also the subnational risk factors that require targeted 
interventions to alleviate this burden.
Implications of all the available evidence
By providing estimates of remaining diarrhoeal burden at various spatial scales, we have 
identified countries and locations that are still most in need of preventive and protective 
measures. Our results indicate that regions with the highest burden had varied exposure to 
select risk factors; however, similar to previous studies, most high-burden areas showed 
some combination of poor WASH, high CGF, and low oral rehydration solution coverage. 
In view of the limited resources in many LMICs, quantification of both the local burden 
of diarrhoea and its drivers is important to maximise impact.
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Figure 1. Mapping of diarrhoea incidence among children younger than 5 years in low-income 
and middle-income countries by second administrative-level unit, 2017
Estimated mean incidence rate per 1000 children in 2017 (A). Absolute deviation from mean 
incidence rate by country in 2017 (B). Annualised decrease in diarrhoea incidence rate from 
2000 to 2017 (C). Estimated mean number of cases of diarrhoea among children in 2017 
(D). All panels are aggregated to the second administrative-level unit. Maps reflect 
administrative boundaries, land cover, lakes, and population; grey-coloured grid cells were 
classified as barren or sparsely vegetated and had fewer than ten people per 1 × 1 km grid 
cell, or were not included in these analyses.33–38
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Figure 2. Mapping of diarrhoeal mortality among children younger than 5 years in low-income 
and middle-income countries by second administrative-level unit, 2017
Estimated mean mortality rate per 1000 children in 2017 (A). Absolute deviation from the 
mean mortality rate by country in 2017 (B). Annualised decrease in diarrhoeal mortality rate 
from 2000 to 2017 (C). Estimated mean number of diarrhoeal deaths among children in 
2017 (D). All panels are aggregated to the second administrative-level unit. Maps reflect 
administrative boundaries, land cover, lakes, and population; grey-coloured grid cells were 
classified as barren or sparsely vegetated and had fewer than ten people per 1 × 1 km grid 
cell, or were not included in these analyses.33–38
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Figure 3. Relative geographical inequality of childhood diarrhoeal mortality in Indonesia and 
Peru in 2000 and 2017
Relative deviation of second administrative-level units from country mean for Indonesia in 
2000 (A), Indonesia in 2017 (B), Peru in 2000 (C), and Peru in 2017 (D). Maps reflect 
administrative boundaries, land cover, lakes, and population; grey-coloured grid cells were 
classified as barren or sparsely vegetated and had fewer than ten people per 1 × 1 km grid 
cell, or were not included in these analyses.33–38
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Figure 4. Geographical inequality of childhood diarrhoeal mortality at the second 
administrative-level unit
The left panel shows the range of relative deviation from the country mean diarrhoea 
mortality rate for each country in 2000 (upper bar) and 2017 (lower bar, coloured by GBD 
super-region). Each bar represents the range from the lowest to highest second 
administrative-level unit deviation for each country. The right panel shows LMICs with at 
least one death from diarrhoea per 10 000 children at the second administrative-level unit 
ranked by childhood diarrhoea mortality rate in 2017. Mean mortality rates are shown as 
dark grey dots and are national-level aggregations that correspond to the results shown in 
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figure 3. Each bar represents the range from the lowest to highest second administrative-
level unit childhood diarrhoeal mortality rate for each country in 2000 (upper bar) and 2017 
(lower bar, coloured by GBD super-region). Country names in both panels are the designated 
ISO 3166-1 alpha-3 codes. GBD=Global Burden of Diseases, Injuries, and Risk Factors 
Study. LMICs=low-income and middle-income countries.
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Figure 5. Averted diarrhoeal deaths in 2017 attributable to improvements in key risk factors 
implemented from 2000 to 2017
Number of deaths averted per 1000 children (A). Number of total deaths averted (B). 
Number of deaths averted per 1000 children with colour scale driven by dominant driver (C). 
Number of total deaths averted with colour scale driven by dominant driver (D). The risk 
factor contributing most of the reduction is indicated as either WASH (blue), CGF (purple), 
and none (gold), in which none represents locations where neither risk factor is dominant. 
Maps reflect administrative boundaries, land cover, lakes, and population; grey-coloured 
grid cells were classified as barren or sparsely vegetated and had fewer than ten people per 1 
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× 1 km grid cell, or were not included in these analyses.33–38 WASH water, sanitation, and 
hygiene. CGF=child growth failure.
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Figure 6. Second administrative-level units in sub-Saharan Africa with childhood mortality rates 
in the lower 20%
Second administrative units are coloured according to where children are most likely to die 
of diarrhoea, or the lower 20% (A). Scatter plots of mortality rates against ORS coverage 
(B),21 access to improved sanitation (C), and childhood stunting prevalence (D). The left 
axes are based on 2000 values whereas the right axes are based on 2017 values. The scale 
change in the y axis is due to substantial decline in mortality rates across most of sub-
Saharan Africa. Because lower 20% is itself a relative distinction, scales are adjusted 
accordingly. Maps reflect administrative boundaries, land cover, lakes, and population; grey-
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coloured grid cells were classified as barren or sparsely vegetated and had fewer than ten 
people per 1 × 1 km grid cell, or were not included in these analyses.33–38 ORS=oral 
rehydration solution.
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